Recognition and Treatment of Infections in ESKD and AKI in Sepsis – A Special World Kidney Day Event

March 9, 2023

Webinar Description: 

Studies have shown that death from sepsis in end-stage kidney disease (ESKD) patients can be up to 50% higher than that of the general population. Furthermore, acute kidney injury (AKI) is a frequent complication associated with sepsis, and AKI from sepsis carries an increased risk of morbidity and mortality.  
During this special World Kidney Day webinar, presented by Sepsis Alliance, presenters will overview infections and sepsis risk factors, outcomes, hemodialysis access considerations, and treatments for ESKD patients. Participants will also learn about AKI risk factors from sepsis, and review treatments, outcomes, and post-sepsis and AKI recovery.  

Target Audience

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more. 

Learning Objectives

At the end of the activity, the learner should be able to: 

  • Review risk factors and outcomes of sepsis in ESKD; 
  • List hemodialysis access type and management considerations; 
  • Explain peritonitis and sepsis management in peritoneal dialysis patients; 
  • Discuss sepsis and AKI as concomitant risk factors; 
  • Describe sepsis and AKI treatments; 
  • Recall sepsis and AKI outcomes and recovery. 

Sepsis Alliance gratefully acknowledges the support provided for this webinar by the Sepsis Alliance Clinical Community sponsors.

Course summary
Available credit: 
  • 1.00 Participation
  • 1.20 RN CE Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider Number CEP17068.
Course opens: 
Course expires: 
Event starts: 
03/09/2023 - 12:00pm PST
Event ends: 
03/09/2023 - 1:00pm PST

Leslie P. Wong MD, MBA, FACP, FASN

Senior Medical Director of Kidney Services and Nephrology; Chief Kidney Health Officer, Intermountain Healthcare

Leslie Wong, MD, MBA, FACP, FASN, is Intermountain Healthcare's Senior Medical Director of Kidney Services and Nephrology, and Chief Kidney Health Officer. In this capacity, Dr. Wong leads Intermountain’s efforts to deliver nationally recognized, valued-based care with an emphasis on reducing the incidence of kidney failure and improving the kidney health of communities across the Mountain West region of the United States.  
Dr. Wong came to Intermountain from dual roles as Chief Medical Officer of Nephrology Care Alliance, a division of DaVita Inc., and Associate Medical Director of Cleveland Clinic's Medicare Accountable Care Organization. He is a seasoned nephrologist who has served as Cleveland Clinic's Vice-Chairman of Nephrology and Hypertension with an emphasis on clinical transformation, as the Director of the Center for Dialysis, and as an associate professor of medicine at Case Western Reserve University.  
Dr. Wong is a graduate of the University of Texas Southwestern Medical School. He completed his residency and fellowship training at the University of North Carolina, where he was Chief Resident. He started his career in Seattle, where he was Medical Director of Peritoneal Dialysis at Northwest Kidney Centers. Following this work, he became Satellite Healthcare's Vice President of Clinical Affairs, leading quality and medical director education at that institution. He also served on the faculty at Stanford University.  
Professionally, he is a nationally recognized nephrology educator and speaker. He is a past member of the American Society of Nephrology (ASN) Dialysis Advisory Group and Chair of Quality, Assessment, Improvement, and Education for Nephrologists Transforming Dialysis Safety (NTDS). Dr. Wong currently participates in the ASN Diabetic Kidney Collaborative and serves on the Excellence in Patient Care (EPC) Committee, helping to guide ASN’s clinical initiatives.  

Anitha Vijayan, MD

Professor of Medicine Division of Nephrology, Washington University in St. Louis; Medical Director, Acute Dialysis Services, Barnes-Jewish Hospital

Anitha Vijayan, MD is professor of medicine in the Division of Nephrology, and the Medical Director of Acute Dialysis Services at Barnes-Jewish Hospital. She is a member of the American Society of Nephrology COVID-19 and Emerging Threats Response Team and the Chair of the AKINOW Recovery Sub-Committee. Her main area of clinical and research interest is improving outcomes in critically ill patients with AKI. 

Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.

Other healthcare providers will receive a certificate of attendance for 1 contact hour.

Medical Disclaimer

The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare provider. Sepsis Alliance recommends users consult their physician or healthcare provider regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

Available Credit

  • 1.00 Participation
  • 1.20 RN CE Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider Number CEP17068.
Please login or register to take this course.

To register for this webinar, please follow these steps:

  1. If you have a Sepsis Alliance Institute account, select Login. If you do not yet have an account, select Register to create your FREE account. 
  2. Select Take Course, then select Take Course again.
  3. Click Start under the Webinar (Via Zoom) tab in the course outline to complete your registration. You MUST do this step to receive your Zoom join link.

Please don't hesitate to reach out to us at with any questions.